Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Investing Activities ₹-12,683 Cr₹-2,082 Cr₹-1,054 Cr₹-1,369 Cr₹-1,222 Cr

What is the latest Cash Flow from Investing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Investing Activities ratio of MANKIND PHARMA is ₹-12,683 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Investing Activities
Mar2025₹-12,683 Cr
Mar2024₹-2,082 Cr
Mar2023₹-1,054 Cr
Mar2022₹-1,369 Cr
Mar2021₹-1,222 Cr

How is Cash Flow from Investing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2025 ₹-12,683 Cr
Negative
Mar2024 ₹-2,082 Cr
Negative
Mar2023 ₹-1,054 Cr
Negative
Mar2022 ₹-1,369 Cr
Negative
Mar2021 ₹-1,222 Cr -

Compare Cash Flow from Investing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹91,067.8 Cr -1.9% -8.2% -13.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,248.0 Cr -0.2% 5.8% 0.9% Stock Analytics
DIVIS LABORATORIES ₹171,344.0 Cr -0.6% -5.2% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,832.0 Cr -0.5% 2.5% 12.1% Stock Analytics
CIPLA ₹121,820.0 Cr -1.1% -0.2% -1.2% Stock Analytics
DR REDDYS LABORATORIES ₹106,877.0 Cr 2.4% 7% 6.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.9%

-8.2%

-13.5%

SENSEX

-0.6%

1.4%

7.7%


You may also like the below Video Courses